Anne Schuchat, Centers for Disease Control and Prevention (USA) & Jean-Claude.
Desenclos, Institut de Veille Sanitaire (France).
Section I: Introduction and Program-Area Surveillance Systems.
1 Infectious Disease Surveillance: A Cornerstone for Prevention and Control.
Nkuchia M. M’ikanatha (Pennsylvania Department of Health), Ruth Lynfield, Kathleen G. Julian (Division of Infectious Disease), Chris A. Van Beneden (Respiratory Diseases Branch),.
Henriette de Valk (Infectious Disease Department).
2 Infectious Disease Surveillance and the International Health Regulations.
Bruce J. Plotkin, Max Hardiman, Fernando Gonz´alez-Mart´ın, Gu´ena¨el Rodier.
3 Active, Population-Based Surveillance for Infectious Diseases.
Chris A. Van Beneden (Respiratory Diseases Branch), Sonja J. Olsen (Thai Ministry of Public Health - Us Cdc Collaboration), Tami H. Skoff (Centers for Disease Control and Prevention), Ruth Lynfield.
4 Surveillance for Antimicrobial-Resistant Streptococcus pneumoniae.
Matthew R. Moore (Centres for Disease Control and Prevention), Ruth Lynfield, Cynthia G. Whitney (Centres for Disease Control and Prevention).
5 Surveillance for Foodborne Diseases.
Elaine Scallan (Enteric Diseases Epidemiology Branch), Frederick J. Angulo.
6 Supranational Surveillance in the European Union.
Andrea Ammon (European Centre for Disease Prevention and Control), Henriette de Valk (Infectious Disease Department).
7 Surveillance for Antimicrobial Resistance among Foodborne Bacteria:.
The US Approach.
Jean M. Whichard (National Antimicrobial Resistance Surveillance Team), Kathryn Gay (Centre for Disease Control and Prevention), David G. White (National Antimicrobial Resistance Monitoring System), Tom M. Chiller (Centers for Disease Control and Prevention).
8 Surveillance for Zoonotic Diseases.
Mira J. Leslie (Washington State Department of Health), Jennifer H. McQuiston (Centers for Disease Control and Prevention).
9 Surveillance for Vector-Borne Diseases.
James L. Hadler (CT Department of Public Health), Lyle R. Petersen (Division of Vector-borne Infectious Disease).
10 Surveillance for Agents of Bioterrorism in the United States.
Richard N. Danila (Minnesota Department of Health), Aaron T. Fleischauer (Bioterrorism Preparedness and Response Branch).
11 Surveillance for Unexplained Infectious Disease-Related Deaths.
Sarah Reagan, Ruth Lynfield (Minnesota Department of Health), Kurt B. Nolte (New Mexico Office of the Medical Investigator), Marc Fischer (Centers for Disease Control and Prevention).
12 Surveillance for Tuberculosis in Europe.
Dennis Falzon (EuroTB, Institut de Veille Sanitaire), Elmira Ibraim (NTP Romania), Andrea Infuso.
13 Surveillance for Healthcare-Associated Infections.
Petra Gastmeier (Hanover Medical School), Bruno Coignard (Infectious Diseases Department), Teresa Horan (Division of Healthcare Quality Promotion).
14 Surveillance for Methicillin-Resistant Staphylococcus aureus (MRSA).
in the Community.
R. Monina Klevens (Division of Healthcare Quality Promotion), Kathleen Harriman (Minnesota Department of Health), Melissa A. Morrison (Centers for Disease Control and Prevention).
15 Surveillance for Viral Hepatitis.
Mary Ramsay, Koye Balogun (Immunisation Department), Catherine Quigley (Health Protection Agency).
16 Surveillance for HIV/AIDS in the United States.
Eve D. Mokotoff (Michigan Dept of Community Health (MDCH)), M. Kathleen Glynn (Division of HIV/AIDS Prevention).
17 Surveillance for Sexually Transmitted Diseases.
Samuel L. Groseclose (National Center for HIV, STD and TB Prevention), Michael C. Samuel (CA DHS STD Control Branch), Hillard Weinstock (Medical Epidemiologist; Lead, Surveillance & Special Studies Team).
18 Vaccine Preventable Diseases.
Part 1: Vaccine Preventable Disease Surveillance.
Hanna Nohynek (Finish Public Health Institute) & Elizabeth Miller (Head of Imunisation Department).
Part 2: Public Health Surveillance for Vaccine Adverse Events.
John K. Iskander (Centers for Disease Control and Prevention), Robert T. Chen ((MS-E45) Epidemiology Branch).
19 Seasonal and Pandemic Influenza Surveillance.
Lynnette Brammer (Centers for Disease Control and Prevention), Alicia Postema (Influenza branch), Nancy Cox (National Center For Immunization & Respiratory Diseases).
20 Communicable Disease Surveillance in Complex Emergencies.
Marta Valenciano (European Programme for Invention Epidemiology), Alain Moren (Medical Epidemiologist).
Section II: Use of Electronic and Web-Based Means.
in Infectious Disease Surveillance.
21 Use of the World Wide Web to Enhance Infectious Disease Surveillance.
Nkuchia M. M’ikanatha (Pennsylvania Department of Health), Dale D. Rohn (Maryland Department of Health and Mental Hygiene), David P. Welliver (Penn State Milton S. Hershey Medical Center), Toby McAdams (Minnesota Department of Health),.
Kathleen G. Julian (Division of Infectious Disease).
22 The Netherlands’ Infectious Diseases Surveillance Information System (ISIS).
Arnold Bosman (National Institute for Public Health and the Environment), Hans van Vliet (Centre for Infectious Disease Control).
23 The Global Public Health Intelligence Network.
Abla Mawudeku (Global Public Health Intelligence Network - GPHIN), Richard Lemay (Global Public Health Intelligence Network (GPIN)), Denise Werker (Department of Communicable Disease), Roberta Andraghetti (Department of Epidemic & Pandemic Response),.
Ron St. John (St John Public Health Consult International Inc).
24 National Notifiable Disease Surveillance in Egypt.
Frank Mahoney (Eastern Mediterranean Regional Office), Rana A. Hajjeh (Centers for the Disease Control and Prevention), Gerald F. Jones, Maha Talaat,.
Abdel-Nasser Mohammed Abdel Ghaffar (Epidemiology and Surveillance Unit).
25 Electronic Reporting in Infectious Disease Surveillance.
Part 1: Basic Principles of Electronic Public Health Surveillance.
G´erard Krause (Department for Infectious Disease Epidemiology), Hermann Claus.
Part 2: Electronic Clinical Laboratory Reporting for Public.
Perry F. Smith (New York State Department of Health), Guthrie S. Birkhead (New York State Department of Health).
26 Implementing Syndromic Surveillance Systems in the Climate.
Julie A. Pavlin, Farzad Mostashari.
Section III: Methods for Surveillance Data Analysis,.
Communication, and Evaluation.
27 Software Applications for Analysis of Surveillance Data.
John H. Holmes (Center for Clinical Epidemiology and Biostatistics), Dale D. Rohn (Maryland Department of Health and Mental Hygiene), Joseph M. Hilbe (School of Social and Family Dynamics, Arizona State University).
28 Analysis and Interpretation of Reportable Infectious Disease Data.
Mindy J. Perilla (Johns Hopkins Bloomberg School of Public Health), Elizabeth R. Zell (Centers for Disease Control and Prevention).
29 Analysis and Interpretation of Case-Based HIV/AIDS Surveillance Data.
Lisa M. Lee (Centers for Disease Control and Prevention), George W. Rutherford (University of California, San Francisco).
30 Use of Molecular Epidemiology in Infectious Disease Surveillance.
John Besser (Minnesota Department of Health).
31 Use of Geographic Information Systems and Remote Sensing for Infectious.
Edmund Seto (University of California, Berkeley), Chester G. Moore (Department of Microbiology, Immunolgy & Pathology), Richard E. Hoskins (Washington State Department of Health).
32 Communication of Information about Surveillance.
Part 1: Media Communication of Information about Infectious Disease.
Surveillance and Outbreaks.
Brian G. Southwell (University of Minnesota).
Part 2: Case Study: A Healthy Response to Increases in Syphilis in.
Jeffrey D. Klausner (San Francisco Department of Public Health), Katherine Ahrens.
33 Evaluation of Surveillance Systems for Early Epidemic Detection.
James W. Buehler (Department of Epidemiology), Daniel M. Sosin (Senior Advisor for Science), Richard Platt (Harvard Medical Shool & Harvard Pilgrim Health Care).
Section IV: Law, Ethics, Training, and Partnership in Infectious.
34 Ethics and the Conduct of Public Health Surveillance.
Amy L. Fairchild (Center for The History and Ethics and Public Health), Marian Moser Jones (Columbia University Mailman School of Public Health).
35 Legal Considerations in Surveillance, Isolation, and Quarantine.
Part 1: Legal Basis for Infectious Disease Surveillance and Control.
Richard E. Hoffman (Department of Preventive Medicine and Biometrics), Renny Fagan (State Services Station).
Part 2: Legal Considerations for Isolation and Quarantine in the.
Frederic E. Shaw (Public Health Law Program), Richard A. Goodman.
36 Training in Applied Epidemiology and Infectious Disease Surveillance:.
Contributions of the Epidemic Intelligence Service.
Denise Koo (Office of Workforce and Career Development), Douglas H. Hamilton (Epidemic Intelligence Service Program), Stephen B. Thacker (Centers for Disease Control and Prevention).
37 New York State International Training Program for Fogarty Fellows.
Dale L. Morse, Louise-Anne McNutt (University of Albany), Robert A. Bednarczyk (State University of New York).
38 Public–Private Partnerships in Infectious Disease Surveillance.
Andrew Friede (Constella Group, LLC).
Section V: Conclusions.
39 Lessons Learned from Smallpox Eradication and Severe Acute Respiratory.
Part 1: The Use of Surveillance in the Eradication of Smallpox and.
D. A. Henderson (University of Pittsburgh Medical Centre).
Part 2: SARS Surveillance in Hong Kong and the United States during the 2003.
Lauren J. Stockman (Centers for Disease Control and Prevention), Thomas Tsang (Consultant Community Medicine), Umesh D. Parashar (Centers for Disease Control and Prevention).
40 Future Directions in Infectious Disease Surveillance.
Ruth Lynfield (Minnesota Department of Health), Nkuchia M. M’ikanatha (Pennsylvania Department of Health), Chris A. Van Beneden (Respiratory Diseases Branch), Henriette de Valk (Infectious Disease Department).
“This significant new text aimed at the 'public health workforce' draws on selected best practices to give comprehensive practical advice on the design and organization of infectious disease … .Time spent delving into this book is richly rewarding, with the text drawing on the expertise of more than 100 authors with many years of experience in disease surveillance. Useful links to surveillance-related Web sites are provided throughout … it is certainly current and up-to-date. This is a valuable book that, if taken up by the public health community, could contribute greatly to improved surveillance for human infectious diseases.” Journal of the American Medical Association
“Authors do a good job of explaining the value of surveillance and how it is used … readable textbook from a highly credible team of expert authors.”
New England Journal of Medicine
“The book is well organized to … provide easy access to the material … special emphasis on the use of information technology analysis and data analysis is particularly strong.”
Doodys Book Reviews
- Includes an overview of major surveillance systems and the newly revised International Health Regulations (IHR 2005, written by officials from the World Health Organization)
- Written by the world's leading experts
- Provides a wide international perspective on best practices
- Content can be adapted for teaching purposes